Cargando…
Efficacy of Dual Inhibition of Glycolysis and Glutaminolysis for Therapy of Renal Lesions in Tsc2(+/−) Mice()
Tuberous sclerosis is caused by mutations in the TSC1 or TSC2 gene and characterized by development of tumors in multiple organs including the kidneys. TSC-associated tumors exhibit somatic loss of the second allele of the TSC genes, leading to aberrant activation of the mechanistic target of rapamy...
Autores principales: | Jones, Ashley T., Narov, Kalin, Yang, Jian, Sampson, Julian R., Shen, Ming Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324218/ https://www.ncbi.nlm.nih.gov/pubmed/30622053 http://dx.doi.org/10.1016/j.neo.2018.12.003 |
Ejemplares similares
-
The dual PI3K/mTOR inhibitor GSK2126458 is effective for treating solid renal tumours in Tsc2(+/-) mice through suppression of cell proliferation and induction of apoptosis
por: Narov, Kalin, et al.
Publicado: (2017) -
Combination of Everolimus with Sorafenib for Solid Renal Tumors in Tsc2(+/−) Mice Is Superior to Everolimus Alone()
por: Yang, Jian, et al.
Publicado: (2017) -
Assessment of Response of Kidney Tumors to Rapamycin and Atorvastatin in Tsc1(+/−) Mice
por: Shen, Ming Hong, et al.
Publicado: (2017) -
Allosteric and ATP-Competitive Inhibitors of mTOR Effectively Suppress Tumor Progression-Associated Epithelial-Mesenchymal Transition in the Kidneys of Tsc2(+/−) Mice
por: Jones, Ashley T., et al.
Publicado: (2019) -
Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis
por: Ahmed, Shanzay, et al.
Publicado: (2023)